
Editor’s Note: This dispatch from ACC.21 was written by Daniel Pipilas, MD, a general cardiology fellow at Massachusetts General Hospital. Dr. Pipilas is also a correspondent with CardioNerds (@CardioNerds), a DocWire News partner. Follow Dr. Pipilas on Twitter (@DPipilasMD).
WASHINGTON– A randomized clinical trial that investigated patients who suffered out-of-hospital cardiac arrest (OHCA) with a hyperinvasive resuscitation approach was terminated early when the hyperinvasive approach showed benefit in a subset of patients. The study results were presented at the American College of Cardiology Scientific Session (ACC.21).
OHCA occurs in more than 350,000 people per year in the US.1 Despite efforts to increase basic life support education and access to automated external defibrillators, meaningful survival is poor. In cases of refractory OHCA, placing patients on VA-ECMO while CPR is ongoing (E-CPR) has shown promise in small observational studies and one small RCT (ARREST trial).2 Current guidelines do not comment on the use of E-CPR.